Fluorine Chemistry Platform

For nearly half a century medicinal chemists have sought to incorporate the benefits of fluorine into a broader range of drug structures. In carefully defined conditions, fluorine can improve potency, stability and safety, and other critical drug attributes. Innovative breakthroughs by Fluorinov Pharma, which was acquired by Trillium in 2016, enable unique, proprietary fluorine chemical synthesis that has the potential to transform promising compounds into superior drugs. Integrating insights from validated, clinically active compounds, with Trillium’s Discovery Platform, this strategy can rapidly yield a rich pipeline of lower-risk new chemical entities with superior properties. By using the unique possibilities of fluorine-based synthetic chemistry, Trillium’s technology also has the potential to access novel drug targets.

Fluorine Chemistry Platform


Email Address: *
First Name:
Mailing Lists

Enter the code shown above.

Powered By Q4 Inc.